Skip to main content

Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis

Publication ,  Journal Article
Komic, A; Martinez-Quinones, P; McCarthy, CG; Webb, RC; Wenceslau, CF
Published in: Clinical Science
July 18, 2018

Sepsis is a profoundly morbid and life-threatening condition, and an increasingly alarming burden on modern healthcare economies. Patients with septic shock exhibit persistent hypotension despite adequate volume resuscitation requiring pharmacological vasoconstrictors, but the molecular mechanisms of this phenomenon remain unclear. The accumulation of misfolded proteins is linked to numerous diseases, and it has been observed that soluble oligomeric protein intermediates are the primary cytotoxic species in these conditions. Oligomeric protein assemblies have been shown to bind and activate a variety of pattern recognition receptors (PRRs) including formyl peptide receptor (FPR). While inhibition of endoplasmic reticulum (ER) stress and stabilization of protein homeostasis have been promising lines of inquiry regarding sepsis therapy, little attention has been given to the potential effects that the accumulation of misfolded proteins may have in driving sepsis pathogenesis. Here we propose that in sepsis, there is an accumulation of toxic misfolded proteins in the form of soluble protein oligomers (SPOs) that contribute to the inflammation and vascular dysfunction observed in sepsis via the activation of one or more PRRs including FPR. Our laboratory has shown increased levels of SPOs in the heart and intrarenal arteries of septic mice. We have also observed that exposure of resistance arteries and vascular smooth muscle cells to SPOs is associated with increased mitogen-activated protein kinase (MAPK) signaling including phosphorylated extracellular signal-regulated kinase (p-ERK) and p-P38 MAPK pathways, and that this response is abolished with the knockout of FPR. This hypothesis has promising clinical implications as it proposes a novel mechanism that can be exploited as a therapeutic target in sepsis.

Duke Scholars

Published In

Clinical Science

DOI

EISSN

1470-8736

ISSN

0143-5221

Publication Date

July 18, 2018

Volume

132

Issue

13

Start / End Page

1433 / 1438

Publisher

Portland Press Ltd.

Related Subject Headings

  • Cardiovascular System & Hematology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Komic, A., Martinez-Quinones, P., McCarthy, C. G., Webb, R. C., & Wenceslau, C. F. (2018). Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis. Clinical Science, 132(13), 1433–1438. https://doi.org/10.1042/cs20180368
Komic, Amel, Patricia Martinez-Quinones, Cameron G. McCarthy, R Clinton Webb, and Camilla F. Wenceslau. “Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis.” Clinical Science 132, no. 13 (July 18, 2018): 1433–38. https://doi.org/10.1042/cs20180368.
Komic A, Martinez-Quinones P, McCarthy CG, Webb RC, Wenceslau CF. Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis. Clinical Science. 2018 Jul 18;132(13):1433–8.
Komic, Amel, et al. “Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis.” Clinical Science, vol. 132, no. 13, Portland Press Ltd., July 2018, pp. 1433–38. Crossref, doi:10.1042/cs20180368.
Komic A, Martinez-Quinones P, McCarthy CG, Webb RC, Wenceslau CF. Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis. Clinical Science. Portland Press Ltd.; 2018 Jul 18;132(13):1433–1438.

Published In

Clinical Science

DOI

EISSN

1470-8736

ISSN

0143-5221

Publication Date

July 18, 2018

Volume

132

Issue

13

Start / End Page

1433 / 1438

Publisher

Portland Press Ltd.

Related Subject Headings

  • Cardiovascular System & Hematology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences